1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Individual patient information on demographics, histology, treatment, and outcome
Patient No. Age (y)/Sex Diagnosis ADC Value (×10−6 mm2/s) ADC Ratio Treatment F/U (y) Treatment Response TTP (y) F/U Results 1 4.7/F PXA XRT/Chemo 14.8 PD 8.6 Alive 2 4.8/M PXA 838 1.06 Sx (3)/XRT 5.0 PD 2.7 Alive 3 7.1/F Anap. PXA Sx (2)/XRT/Chemo 0.5 PD 0.2 Died 4 9.3/F PXA 928 1.24 Sx 7.7 CR n/a Alive 5 4.5/F PXA 668 0.85 Sx Lost to F/U 6 6.9/M PXA 1189 1.47 Sx (3) 9.6 PD 3.8 Alive 7 16.1/M PXA 889 1.28 Sx 3.4 CR n/a Alive 8 6.1/M Anap. PXA 825 0.75 Sx/XRT/Chemo 4.0 CR n/a Alive 9 11.6/M PXA 762 1.32 Sx Lost to F/U 10 14.0/F PXA Sx/XRT/Chemo 8.2 PD 0.8 Died 11 13.0/M Anap. PXA Sx/XRT/Chemo 2.5 CR n/a Alive
Note:—Anap. indicates anaplastic; Chemo, chemotherapy; CR, complete remission; F/U, follow-up; PD, progressive disease; Sx, surgery; XRT, radiotherapy.